Patrick M. Reagan
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 55
- CAR-T cell therapy research 47
- Cancer Immunotherapy and Biomarkers 4
-
- Lymphoma Diagnosis and Treatment 42
- Co-authors
- Sattva S. Neelapu (18 shared papers)Frederick L. Locke (29 shared papers)Jonathan W. Friedberg (21 shared papers)David B. Miklos (26 shared papers)Caron A. Jacobson (26 shared papers)Lazaros J. Lekakis (16 shared papers)Yi Lin (14 shared papers)Olalekan O. Oluwole (18 shared papers)
- Journals
- Blood (21 papers)Journal of Clinical Oncology (18 papers)Blood Advances (6 papers)Hematological Oncology (3 papers)Transplantation and Cellular Therapy (3 papers)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Patrick M. Reagan
81 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 88
- Oncology 945
- Pathology and Forensic Medicine 290
- Immunology 333
- Genetics 106
- Genetics 187
Countries citing papers authored by Patrick M. Reagan
This map shows the geographic impact of Patrick M. Reagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick M. Reagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick M. Reagan more than expected).
Fields of papers citing papers by Patrick M. Reagan
This network shows the impact of papers produced by Patrick M. Reagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick M. Reagan. The network helps show where Patrick M. Reagan may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick M. Reagan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 282 | |
| 2 | 2018 | 147 | |
| 3 | 2022 | 73 | |
| 4 | 2010 | 65 | |
| 5 | 2021 | 63 | |
| 6 | 2021 | 52 | |
| 7 | 2019 | 52 | |
| 8 | 2017 | 44 | |
| 9 | 2013 | 43 | |
| 10 | 2021 | 34 | |
| 11 | 2009 | 25 | |
| 12 | 2021 | 24 | |
| 13 | 2017 | 24 | |
| 14 | 2010 | 23 | |
| 15 | 2017 | 21 | |
| 16 | 2018 | 20 | |
| 17 | 1969 | 19 | |
| 18 | 2019 | 18 | |
| 19 | 2018 | 18 | |
| 20 | 2017 | 17 |
About Patrick M. Reagan
Patrick M. Reagan is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Immunology and Electrical and Electronic Engineering, having authored 85 papers that have together received 1.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (47 papers), Lymphoma Diagnosis and Treatment (42 papers), Chronic Lymphocytic Leukemia Research (20 papers), Biosimilars and Bioanalytical Methods (13 papers), Integrated Circuits and Semiconductor Failure Analysis (6 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Advancements in Semiconductor Devices and Circuit Design (4 papers). The work is most often cited by research in Oncology (945 citations), Pathology and Forensic Medicine (290 citations), Immunology (333 citations), Genetics (106 citations) and Genetics (187 citations). Patrick M. Reagan has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Sattva S. Neelapu, Frederick L. Locke, Jonathan W. Friedberg, David B. Miklos, Caron A. Jacobson, Lazaros J. Lekakis, Yi Lin, Olalekan O. Oluwole, John M. Rossi and Adrian Bot. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Hematological Oncology and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.